Alpha Teknova (TKNO) Cash from Investing Activities (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Cash from Investing Activities came in at $1.8 million in Q1 2026, down 51.86% year-on-year from $3.8 million in Q1 2025, and down 42.59% on a QoQ basis from $3.2 million in Q4 2025.
Alpha Teknova (TKNO) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Cash from Investing Activities data on file, last reported at $1.8 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 51.86% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $8.7 million, a 137.15% increase from a year earlier, with the FY2025 full-year figure at $10.7 million, up 139.23% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $1.8 million, down from $3.2 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for TKNO reached as high as $3.8 million in Q1 2025 and fell as low as -$25.8 million in Q3 2024.
- Historically, Cash from Investing Activities has averaged -$3.0 million across 5 years, with a median of -$972000.0 in 2023.
- Across the five-year window, Cash from Investing Activities plunged 2550.1% in 2024 and jumped 29315.38% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$4.7 million in 2022, then surged by 97.57% to -$115000.0 in 2023, then slumped by 1129.57% to -$1.4 million in 2024, then soared by 326.8% to $3.2 million in 2025, then slumped by 42.59% to $1.8 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $1.8 million in Q1 2026, $3.2 million in Q4 2025, and $1.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 229.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -87.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -369.95 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 743.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 277.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -506.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -60.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 1.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.84 Mn |
| Mar 31, 2026 | 1.84 Mn |
| Dec 31, 2025 | 3.21 Mn |
| Dec 31, 2025 | 3.21 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 3.82 Mn |
| Mar 31, 2025 | 3.82 Mn |
| Dec 31, 2024 | -1.41 Mn |
| Dec 31, 2024 | -1.41 Mn |
| Sep 30, 2024 | -25.76 Mn |
| Sep 30, 2024 | -25.76 Mn |
| Jun 30, 2024 | -115,000.00 |
| Jun 30, 2024 | -115,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | -115,000.00 |
| Dec 31, 2023 | -115,000.00 |